Table 4.
Study | Year | Country | Device | N | Age (yr) | Proportion with diabetes (%) | Dialysis vintage (yr) | Achieved UF Volume (L) |
ΔWeight | ΔBP | ΔIOP | ΔRetinal thickness | ΔChoroidal thickness | ΔRNFL | ΔVessel density |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shin et al.113 | 2019 | South Korea | DRI Triton (Topcon, Tokyo, Japan) | 32 | 56 | ∼66 | 6 | 3 | ↓2.6 kg | ↓SBP ∼12 mm Hg | No change | – | ↓∼5% | – | – |
Shin et al.114 | 2018 | South Korea | DRI OCT1 (Topcon) Atlantis |
29 | 56 | ∼52 | 5.8 | 3 | ↓2.7 kg | ↓SBP ∼10 mm Hg | No change | No change | ↓∼7% | – | ↓∼3% |
Zhang et al.115 | 2018 | China | AngioVue (OptoVue, CA) | 77 | 53 | ∼50 | 4.5 | 2.5 | – | ↓SBP ∼7 mm Hg | No change | ↓∼2% | No change | – | ↓∼3% |
Chen et al.116 | 2018 | China | Cirrus HD (Carl Zeiss AG, Jena, Germany) | 90 | 58 | ∼13 | 5.8 | – | – | ↓SBP ∼10 mm Hg ↓DBP ∼7 mm Hg |
No change | No change | ↓∼12% | ↑∼3% | – |
Chang et al.117 | 2017 | South Korea | SPECTRALIS with EDI (Heidelberg Engineering, Heidelberg, Germany) | 54 | 60 | ∼60 | 5 | – | ↓2.3 kg | ↓SBP ∼15 mm Hg ↓DBP ∼4 mm Hg |
↓∼10% | – | ↓∼10% | No change | – |
Ishibazawa et al.118 | 2015 | Japan | RetinaScan (Nidek, Gamagori, Japan) No EDI |
77 | 67 | ∼50 | 4.7 | 2.5 | ↓2.2 kg | ↓SBP ∼14 mm Hg ↓DBP ∼4 mm Hg |
No change | No change | ↓∼10% | – | – |
Jung et al.119 | 2014 | South Korea | SPECTRALIS (Heidelberg Engineering) No EDI |
19 | 51 | ∼50 | 3.5 | – | ↓2.1 kg | ↓SBP ∼16 mm Hg | No change | – | ↑∼5% | – | – |
Yang et al.120 | 2013 | South Korea | SPECTRALIS with EDI (Heidelberg Engineering) | 34 | 58 | ∼25 | 6 | – | ↓2.8 kg | No change | ↓∼10% | No change | ↓∼6% | No change | – |
Ulas et al.121 | 2013 | Turkey | SPECTRALIS with EDI (Heidelberg Engineering) | 21 | 61 | – | 2.4 | 3 | – | No change | No change | No change | ↓∼10% | – | – |
Jung et al.122 | 2013 | South Korea | SPECTRALIS No EDI (Heidelberg Engineering) |
30 | 54 | ∼40 | 4.3 | – | ↓1.9 kg | ↓SBP ∼17 mm Hg ↓DBP ∼7 mm Hg |
↓∼15% | ↓∼2% | – | – | – |
Theodossiadis et al.123 | 2012 | Greece | OCT3 Stratus (Carl Zeiss AG) | 72 | 62 | 100 | 2.8 | – | ↓2.5 kg | No change | – | ↓∼4% | – | – | – |
Demir et al.124 | 2009 | Turkey | OCT3 Stratus (Carl Zeiss AG) | 36 | 41 | – | 3.5 | – | – | – | – | – | – | No change | – |
↑, increase; ↓, decrease; BP, blood pressure; DBP, diastolic blood pressure; EDI, enhanced depth imaging; IOP, intraocular pressure; OCT, optical coherence tomography; RNFL, retinal nerve fiber layer; SBP, systolic blood pressure; UF, ultrafiltration.
Studies examining OCT metrics before and after a hemodialysis session in patients on long-term renal replacement therapy.
All values are mean.